| | | Frequency of subjects with no delirium | Frequency of subjects with delirium |
| | Gender | | | | Male | 35 (0.73) | 13 (0.27, 0.15 to 0.42) | | Female | 24 (0.69) | 11 (0.31, 0.17 to 0.49) | | Race | | | | White | 51 (0.73) | 19 (0.27, 0.17 to 0.39) | | Asian | 1 (1.0) | 0 (0.0, 0.0 to 0.98) | | Hispanic | 2 (0.67) | 1 (0.33, 0.0 to 0.91) | | Black | 2 (0.67) | 1 (0.33, 0.0 to 0.91) | | Native American | 1 (1.0) | 0 (0.0, 0.0 to 0.98) | | Other | 2 (0.40) | 3 (0.60, 0.15 to 0.95) | | Cancer type | | | | Lung | 1 (0.14) | 6 (0.86, 0.42 to 0.99) | | Central nervous system | 3 (0.50) | 3 (0.50, 0.12 to 0.88) | | Gastrointestinal | 5 (0.63) | 3 (0.38, 0.09 to 0.76) | | Hematological | 23 (0.72) | 9 (0.28, 0.14 to 0.47) | | Sarcoma | 5 (0.83) | 1 (0.17, 0.0 to 0.64) | | Head and neck | 7 (0.88) | 1 (0.13, 0.0 to 0.53) | | Breast | 1 (1.0) | 0 (0.0, 0.0 to 0.98) | | Genitourinary | 0 (0.0) | 1 (1.0, 0.03 to 1.0) | | Gynecological | 11 (1.0) | 0 (0.0, 0.0 to 0.28) | | Neuroendocrine | 2 (1.0) | 0 (0.0, 0.0 to 0.84) | | Skin | 1 (1.0) | 0 (0.0, 0.0 to 0.98) | | Reason for admission | | | | Surgical resection | 9 (1.0) | 0 (0.0, 0.0 to 0.34) | | Chemotherapy | 31 (0.97) | 1 (0.03, 0.0 to 0.16) | | Hematological stem cell transplantation | 5 (0.56) | 4 (0.44, 0.14 to 0.79) | | Acute symptom management | 14 (0.42) | 19 (0.58, 0.39 to 0.75) |
| | | No delirium () | Delirium () |
| | Age | | | | Mean | 43.03 | 51.42 | | Median | 47.0 | 51.50 | | Standard deviation | 11.66 | 3.72 | | Length of stay (days) | | | | Mean | 5.56 | 11.21 | | Median | 4.0 | 6.50 | | Standard deviation | 5.64 | 13.24 | | Total cost | | | | Mean | 15846.03 | 43686.29 | | Median | 9488.0 | 20654.50 | | Standard deviation | 18970.49 | 63617.43 |
|
|
